Literature DB >> 5094584

EXcretion and distribution of iron during chronic deferoxamine therapy.

J N Lukens, L A Neuman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5094584

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Long-term administration of desferrioxamine in thalassaemia major.

Authors:  R Seshadri; J H Colebatch; P Gordon; H Ekert
Journal:  Arch Dis Child       Date:  1974-08       Impact factor: 3.791

2.  Desferrioxamine B: reversible side effects of high daily doses.

Authors:  G Cartei; T Barbui; M Cazzavillan; T Chisesi; E Dini
Journal:  Blut       Date:  1975-07

3.  Injectable Thermosensitive Hydrogels for a Sustained Release of Iron Nanochelators.

Authors:  Seung Hun Park; Richard S Kim; Wesley R Stiles; Minjoo Jo; Lingxue Zeng; Sunghoon Rho; Yoonji Baek; Jonghan Kim; Moon Suk Kim; Homan Kang; Hak Soo Choi
Journal:  Adv Sci (Weinh)       Date:  2022-03-27       Impact factor: 17.521

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.